1. A single-centre, observational, retrospective, real-life study evaluating adalimumab biosimilar ABP 501 in the treatment of plaque-type psoriasis and psoriatic arthritis in originator-naïve patients and in patients undergoing non-medical switch from originator. (3rd July 2021) Authors: Giunta, A.; Zangrilli, A.; Bavetta, M.; Manfreda, V.; Pensa, C.; Bianchi, L. Journal: Current medical research and opinion Issue: Volume 37:Number 7(2021) Page Start: 1099 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Etanercept biosimilar SB4 in the treatment of plaque‐type psoriasis and psoriatic arthritis: a single‐centre, observational, retrospective, real‐life study. (1st November 2019) Authors: Giunta, A.; Manfreda, V.; Esposito, M.; Del Duca, E.; Bianchi, L. Journal: British journal of dermatology Issue: Volume 181:Number 5(2019) Page Start: 1078 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗